🔎 Trials Near Me

Home › Pancreatic Cancer › Montana

Pancreatic Cancer clinical trials in Montana

6 studies for Pancreatic Cancer are looking for participants at sites in Montana.

Cities in Montana

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  • Saint Joseph Hospital - Cancer Centers - St. Vincent Frontier Cancer Center, Billings
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07409272

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • Saint Patrick Hospital - Community Hospital, Missoula
RecruitingObservational study
Ages 50 to 75 · All sexes · Updated Sep 4, 2026 · NCT04239573

Integrated Cancer Repository for Cancer Research

  • Bozeman Health Deaconess Hospital, Bozeman
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06998940

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

  • Ohio State University-Telemedicine, Bozeman
  • Ohio State University Telemedicine, Miles City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06906562

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Billings
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.